Losartan: Medication used to treat hypertension recalled due to trace amounts of possible cancer-causing chemical

A pharmaceutical company has expanded a voluntary recall for medication used to treat hypertension as the medicine includes trace amounts of a chemical that could cause cancer.

According to the Food and Drug Administration , Torrent Pharmaceuticals Limited announced Thursday that it was expanding its voluntary recall of Losartan from two lots to 10 lots.

The recall notification states that the pills contain above the daily accepted levels of N-nitrosodiethylamine (NDEA).

According to the FDA, NDEA is a chemical that can be found in drinking water and some foods, and studies have classified it as a "possible human carcinogen."

Only the lots listed below have been recalled. The FDA says patients should continue to take their medication but contact a doctor immediately to seek advice on a new treatment strategy.

Losartan can also be perscribed to treat hypertensive patients with Left Ventricular Hypertrophy and for the treatment of nephropathy in Type 2 diabetic patients.

See the full list of lots recalled below.